Overview
The Effects of Peri-operative Pregabalin Administration on Post-operative Analgesia in Patients Undergoing Coronary Bypass Grafting
Status:
Unknown status
Unknown status
Trial end date:
2011-06-01
2011-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
We hypothesize that the perioperative administration of pregabalin will significantly decrease pain scores and post-operative opioid requirements for patients undergoing coronary artery bypass grafting, and reduces the incidence of opioid-induced side effects such as respiratory depression. This may reduce ICU admission and possibly abbreviate length of hospital stay.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of ManitobaTreatments:
Pregabalin
Criteria
Inclusion Criteria- Patients whom are able and willing to provide written informed consent.
- Male and female 18-70 years of age.
- Patients whom are undergoing isolated coronary artery bypass grafting through a
midline sternotomy for the treatment of ischemic heart disease.
Exclusion criteria
- Patients undergoing cardiac surgery for valvular or pericardial surgery.
- Patients with a documented ejection fraction of less than 50%.
- Patients with known chronic renal insufficiency and a calculated creatinine clearance
of < 60mL/min.
- Patients with known sensitivity to the study drugs.
- Patients with documented pre-existing chronic pain.
- Patients with seizure disorders.
- Patients whom are taking pregabalin or gabapentin
- Patients on chronic neuroleptic medications for control of psychiatric disorders as to
avoid possible drug interactions and to avoid modulation of any pain states by such
medications.
- Patients whom are taking tricyclic antidepressants or serotonin and norepinephrine
re-uptake inhibitors(SNRI) will be excluded because of the effect of these drugs on
neuropathic pain.
- Patients greater than 70 years of age will also be excluded because of their increased
risk of side-effects and perioperative confusion.
- Pregnant or breast feeding females